Zhixin Huang

Mr. Zhixin Huang

First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2022 in Cancer Communications
Verified
Journal Article
Open access
YLYinan Liu
Yinan Liu
EZErtao Zhai
Ertao Zhai
JCJunting Chen
Junting Chen
YQYan Qian
Yan Qian
RZRisheng Zhao
Risheng Zhao
JCJianhui Chen
Jianhui Chen
Background: Methyltransferase 3 (METTL3)‐mediated N6‐methyladenosine (m 6 A) RNA modification has been demonstrated to be a potential factor in promoting gastric cancer (GC). METTL3 regulates a series of signaling pathways by modifying various mRNAs. This study aimed to identify novel METTL3‐mediated signaling pathways and explored possible targets for use in the clinical setting of gastric cancer. Methods: To investigate the proliferation and metastatic capacity of GC cell lines with METTL3 knockdown, a xenograft, lung metastasis, and popliteal lymph node metastasis model was used. The m 6 A‐modified RNA immunoprecipitation (Me‐RIP) sequence was utilized to explore the target mRNAs of METTL3. Cell counting kit 8 and transwell assays were performed to investigate the promoting function of pre‐B cell leukemia homeobox 1 (PBX1) and GTP cyclohydrolase 1 (GCH1). Western blotting and chromatin immunoprecipitation were employed to confirm the involvement of the METTL3‐PBX1‐GCH1 axis. ELISA and liquid chromatography‐mass spectrometry were used to explore the biological function of tetrahydrobiopterin (BH 4 ). Results: Knockdown of METTL3 suppressed xenograft tumor growth and lung/lymph node metastasis in vivo. Mechanistically, we found that METTL3 combined with and stabilized PBX1 mRNAs. Chromatin immunoprecipitation (ChIP) and further experiments suggested that PBX1 acted as a transcription factor inducing GCH1 expression. Moreover, the METTL3‐PBX1‐GCH1 axis increased BH 4 levels in GC cells, thereby promoting tumor progression. Conclusions: This study suggested that METTL3 enzymes promote tumor growth and lung/lymph node metastasis via METTL3‐PBX1‐GCH1 axis increasing BH4 levels in GC.

6 February 2022 in Helicobacter
Verified
Journal Article
Closed access
PDF file
YLYing Li
Ying Li
ZHZhixin Huang
Zhixin Huang
YSYanyan Shang
Yanyan Shang
XXXinqiang Xie
Xinqiang Xie
RYRunshi Yang
Runshi Yang
QWQingping Wu
Qingping Wu

19 November 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
TZTianhao Zhang
Tianhao Zhang
SLShurong Lai
Shurong Lai
YCYuzhi Cai
Yuzhi Cai
ZHZhixin Huang
Zhixin Huang
YLYing Li
Ying Li
JCJianhui Chen
Jianhui Chen
Background: Gastric cancer (GC) is one of the most common and poor prognosis malignancy in the world. The Family with sequence similarity 83 (FAM83) comprises of eight members of A–H. Accumulating evidence confirmed important roles for FAM83 family in tumorigenesis and progression. However, the prognostic values of FAM83 family in GC still have not been clarified.Methods: ONCOMINE, UALCAN, GEPIA, THE HUMAN PROTEIN ATLAS, Kaplan–Meier Plotter, cBioPortal, DAVID, STRING and TIMER databases and R software were adopted in this study.Results: In this study, we demonstrated that the mRNA levels of FAM83 B/C/D/H were significantly up-regulated in stomach adenocarcinoma (STAD), but the protein level of FAM83G/H were remarkable lowly in STAD. Next, FAM83C/D/G/H were significantly associated with tumor stages in STAD patients. Then, the mutation rate of FAM83 family members in STAD patients was 46%, and the highest mutation rate was FAM83H (23%). Furthermore, the functions of FAM83 family and their 259 co-expression genes were primarily related to Shigellosis, RNA degradation and Ribosome biogenesis in eukaryotes pathway. Besides, we have established the prognostic model of FAM83 family in STAD, including the prognostic model of STAD patients (FAM83C/D/G), STAD with lymph node metastasis (FAM83C/D/G/H) and STAD with ERBB2 high expression (FAM83G/H). FAM83C/D high expression with a poor prognosis, while FAM83G/H high expression with a favorable prognosis of STAD. Additionally, we found that the expression of FAM83C/D/G/H were significantly correlated with the infiltration of six types of immune cells [B cells, CD8+T cells, CD4+T cells, macrophages and Myeloid dendritic cells (DC)], whereas CD4+T cells and Macrophage cells have higher risk scores (HR > 1) when FAM83C lowly expression and FAM83D highly expression. The risk score of NK cells was significantly reduced when FAM83G lowly expression and FAM83H highly expression (HR < 1).Conclusion: These findings suggested that FAM83C/D/G/H might play key roles in STAD tumorigenesis and progression, and FAM83C/D might be risk factors but FAM83G/H might be favorable prognostic factors for STAD patients. In addition, CD4+T cells and Macrophage cells may be the promoters of FAM83D in progression of STAD, while NK cells may promote the protective effect of FAM83H on STAD patients.

28 March 2022 in World Journal of Gastroenterology
Verified
Journal Article
Open access
YLYing Li
Ying Li
WTWen-Hui Tan
Wen-Hui Tan
JWJia-Chuan Wu
Jia-Chuan Wu
ZHZhixin Huang
Zhixin Huang
YSYan-Yan Shang
Yan-Yan Shang
QWQingping Wu
Qingping Wu
Microbiologic risk factors of recurrent choledocholithiasis post-endoscopic sphincterotomy

4 March 2026 in Microbial Genomics
Verified
Journal Article
Open access
YZYing Zhang
Ying Zhang
YSYanyan Shang
Yanyan Shang
ZLZhenkai Li
Zhenkai Li
ZKZupeng Kuang
Zupeng Kuang
SHShixuan Huang
Shixuan Huang
QWQingping Wu
Qingping Wu
Background . Helicobacter pylori infection is a major risk factor for gastric cancer (GC), especially in East Asia. However, the mechanisms through which bacterial strain heterogeneity contributes to GC risk remain poorly understood. This study aims to elucidate the roles of specific virulence factors, antibiotic resistance profiles and genetic variations in H. pylori in GC development. Methods. We integrated host clinical data with phenotypic and genomic analyses of 31 clinical H. pylori isolates. Genomic analysis was performed to determine phylogenetic lineage and virulence markers. Antibiotic susceptibility and biofilm-forming ability of the clinical isolates were also assessed, and a genome-wide association study (GWAS) was employed to identify genetic polymorphisms linked to GC risk. Results. Among the isolates, 93.5 % of isolates belonged to the East Asian lineage and carried high-risk virulence markers ( cagA EPIYA-ABD, vacA s1m1). However, multidrug resistance was observed in 64.5 % of isolates, with high resistance rates to metronidazole (71.0%) and levofloxacin (48.4%) exceeding global averages. Strong biofilm-forming strains were significantly associated with tetracycline resistance compared to weak biofilm-forming strains. Additionally, GWAS identified five SNPs significantly associated with GC risk, with variants in hemC , babB and C694_RS04850 being enriched in high-risk strains. Conclusions. This study demonstrates the critical impact of H. pylori strain diversity in GC development, emphasizing the necessity for region-specific surveillance and innovative therapeutic strategies.